Small cell lung cancer is a type of neuroendocrine tumor (NET). Learn more about the different NETs, including how risk factors, diagnosis, and treatment differ.

Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, discusses how early data from ABBV-706 shows up to 50% ...

Small-cell lung cancer (SCLC) is the most common type of lung neuroendocrine tumor (NET). We review what that means and discuss other types of NETs.

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

Lung neuroendocrine neoplasms (NENs) encompass a spectrum of neoplasms that are subdivided into the well-differentiated neuroendocrine tumors comprising the low- and intermediate-grade typical and ...

AbbVie is exploring this approach with Temab-A in a trial spanning at least seven tumor types, including lung and colorectal cancers being the most advanced. Another investigational therapy, ABBV-706, ...

Small cell lung cancer (SCLC) is one of the hardest types of cancer to treat and has often already spread by the time people are diagnosed. It mainly arises from neuroendocrine (NE) cells, which ...

“At just 40% of the administered dose reported for Ac-DOTATATE, Ac-EBTATE produces enhanced anti-tumor efficacy in small cell lung cancer (SCLC) and Pan-neuroendocrine tumor (NET) models as ...

Harpoon's data from its phase 1/2 study for the treatment of neuroendocrine tumors, is expected to be released in the 1st half of 2024. Read my analysis here.

Researchers have identified 5 key genes that may serve as new treatment targets for small cell lung cancer (SCLC), according to research published in Frontiers in Immunology. 1. The study found ...

The facts on small-cell lung cancer, or SCLC, and non-small-cell lung cancer, or NSCLC, like symptoms, prognosis, treatment, and recovery.